Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Redox metabolism in cell senescence: focusing on contributions from the metabolomic field. | Front Mol Biosci | 2025 | 41624773 | PubTator, text mining | PubMed |
| Editorial: Overcoming resistance in DDR inhibition: new targets and therapeutic strategies. | Front Mol Biosci | 2025 | 41556042 | PubTator, text mining | PubMed |
| Blast Resistance of Confined Multilayer Graded Corrugated-Core Sandwich Cylindrical Shells. | Materials (Basel) | 2025 | 41515768 | PubTator, text mining | PubMed |
| Structure-aware completion of plant 3D LiDAR point clouds via a multi-resolution GAN-inversion network. | Front Plant Sci | 2025 | 41487337 | PubTator, text mining | PubMed |
| DNA mismatch repair mediated by Mlh1-Pms1 endonuclease-catalyzed mispair excision. | Proc Natl Acad Sci U S A | 2025 | 41439704 | PubTator, text mining | PubMed |
| Pathways and products of base excision DNA repair in Xenopus laevis eggs: contrast with human cell pathways. | Nucleic Acids Res | 2025 | 41370197 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis and Experimental Validation of the Role of Cellular Senescence in Osteoporosis. | Calcif Tissue Int | 2025 | 41361583 | PubTator, text mining | PubMed |
| Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapy. | Nucleic Acids Res | 2025 | 41359388 | PubTator, text mining | PubMed |
| JMJD1B-mediated FEN1 demethylation allows timely switching of Okazaki fragment maturation core enzymes to avoid mutagenic flap ligation by PARP1-LIG3. | bioRxiv | 2025 | 41280084 | PubTator, text mining | PubMed |
| XPF mediates 3' flap processing for FEN1-independent Okazaki fragment maturation. | bioRxiv | 2025 | 41279254 | PubTator, text mining | PubMed |
| In Situ-Generated Dual-Catalytic DNAzyme Walkers for High-Fidelity Electrochemiluminescence Detection of FEN1 Activity. | Anal Chem | 2025 | 41211937 | PubTator, text mining | PubMed |
| Shared Plasma Metabolites Mediate Causal Effects of Metabolic Diseases on Colorectal Cancer: A Two-Step Mendelian Randomization Study. | Biomedicines | 2025 | 41153716 | PubTator, text mining | PubMed |
| Barcode-free hit discovery from massive libraries enabled by automated small molecule structure annotation. | Nat Commun | 2025 | 41145427 | PubTator, text mining | PubMed |
| Causal-aware reliability assessment of single-channel EEG for transformer-based sleep staging. | Front Neurosci | 2025 | 41132593 | PubTator, text mining | PubMed |
| Serial innovations by Asgard archaea shaped the DNA replication machinery of the early eukaryotic ancestor. | Nat Ecol Evol | 2025 | 41120633 | PubTator, text mining | PubMed |
| Structure-specific electrochemiluminescent biosensor for FEN1 detection via dumbbell probe-mediated transcription and CRISPR/Cas13a-induced G-quadruplexes cleavage. | Anal Chim Acta | 2025 | 41093525 | PubTator, text mining | PubMed |
| A multi-level signal conversion architecture for enzyme sensing: Integrating MXene nanoplatforms with CRISPR-driven electrochemiluminescence. | Anal Chim Acta | 2025 | 41093508 | PubTator, text mining | PubMed |
| Correction: Proteomics analysis reveals FEN1 as a promising therapeutic target against small cell neuroendocrine carcinoma of the cervix. | Sci Rep | 2025 | 41057633 | PubTator, text mining | PubMed |
| PARP1 auto-modification promotes faithful Okazaki fragment processing and limits replication fork speed. | Mol Cell | 2025 | 41043391 | PubTator, text mining | PubMed |
| Pose ensemble graph neural networks to improve docking performances. | Chem Sci | 2025 | 41030805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=5